Are Circulating Metabolites Important in Pharmacokinetic Drug-Drug Interactions? A Retroanalysis of Clinical Data

E-ISSN： 1875-5453|15|8|767-790

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.15, Iss.8, 2014-01, pp. : 767-790

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Data mining for potential adverse drug–drug interactions

By Hammann Felix Drewe Juergen

Expert Opinion on Drug Metabolism and Toxicology, Vol. 10, Iss. 5, 2014-05 ,pp. : 665-671

Informa Healthcare

Access to resources Recommend Favorite

Editorial (Thematic Issue: Study and Prediction of Pharmacokinetic Drug-Drug Interactions)

Current Drug Metabolism, Vol. 15, Iss. 8, 2014-10 ,pp. : 759-760

Bentham Science Publishers

Access to resources Recommend Favorite

Important Drug Interactions in Dermatology

By Roos T.C. Merk H.F.

Drugs, Vol. 59, Iss. 2, 2000-02 ,pp. : 181-192

Adis International

Access to resources Recommend Favorite

Rosuvastatin-Associated Adverse Effects and Drug-Drug Interactions in the Clinical Setting of Dyslipidemia

By Kostapanos Michael S. Milionis Haralampos J. Elisaf Moses S.

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 1, 2010-02 ,pp. : 11-28

Adis International

Access to resources Recommend Favorite

Clinical Risk Management in Dutch Community Pharmacies: The Case of Drug-Drug Interactions

By Buurma Henk De Smet Peter A.G.M Egberts Antoine C.G.

Drug Safety, Vol. 29, Iss. 8, 2006-01 ,pp. : 723-732

Adis International

Access to resources Recommend Favorite